Welcome to this UK AstraZeneca produced and funded website

This website is intended for UK Healthcare Professionals only.

 

The website contains both promotional and non-promotional content.

 

If you are a patient or a carer of a patient prescribed an AstraZeneca product, please visit myazmed.co.uk

 

For any other UK residents please visit astrazeneca.co.uk

I am not a Healthcare Professional
Prescribing Information FLUENZ® nasal spray suspension (influenza vaccine, live attenuated, nasal)
Adverse Event Reporting

This website is intended for UK Healthcare Professionals only. Other UK residents please visit astrazeneca.co.uk

AstraZeneca-logo
  • Our Medicines
    • Cardiovascular, Renal & Metabolism
      • ATTR Amyloidosis
        • WAINZUA®▼(eplontersen)
      • Chronic Kidney Disease (CKD)
        • FORXIGA® (dapagliflozin)
      • Heart Failure
        • FORXIGA® (dapagliflozin)
      • Hyperkalaemia
        • LOKELMA® (sodium zirconium cyclosilicate)
      • Type 2 Diabetes (T2D)
        • FORXIGA® (dapagliflozin)
    • Oncology
      • Breast Cancer
        • LYNPARZA® (olaparib)
        • TRUQAP®▼(capivasertib)
      • Bladder Cancer
        • IMFINZI® (durvalumab)
      • Endometrial Cancer
        • IMFINZI® (durvalumab)
        • LYNPARZA® (olaparib)
      • Gastrointestinal Cancer
        • IMFINZI® (durvalumab)
        • IMJUDO®▼(tremelimumab)
      • Lung Cancer
        • IMFINZI® (durvalumab)
        • TAGRISSO® (osimertinib)
      • Ovarian Cancer
        • LYNPARZA® (olaparib)
      • Prostate Cancer
        • LYNPARZA® (olaparib)
        • ZOLADEX® (goserelin)
    • Respiratory
      • Asthma
        • TEZSPIRE®▼ (tezepelumab)
        • SYMBICORT® (budesonide/formoterol)
      • Chronic Obstructive Pulmonary Disease(COPD)
        • TRIXEO AEROSPHERE® (formoterol fumarate dihydrate/glycopyrronium/budesonide)
        • BEVESPI® (glycopyrronium/formoterol fumarate dihydrate)
    • Vaccines
      • Flu
        • FLUENZ® nasal spray suspension (influenza vaccine, live attenuated, nasal)
  • Therapy Areas
    • Cardiovascular, Renal & Metabolism
      • ATTR Amyloidosis
      • Chronic Kidney Disease (CKD)
      • Heart Failure
      • Hyperkalaemia
      • Type 2 Diabetes (T2D)
    • Oncology
      • Breast Cancer
      • Bladder Cancer
      • Endometrial Cancer
      • Gastrointestinal Cancer
      • Lung Cancer
      • Ovarian Cancer
      • Prostate Cancer
    • Respiratory
      • Asthma
      • Chronic Obstructive Pulmonary Disease(COPD)
    • Vaccines
      • Flu
  • About us
    • AZ Commitment
  • Contact us
  • AstraZeneca UK
  • Welcome to Fluenz
  • Welcome to Fluenz
  • About Fluenz
  • The Importance of Vaccination
  • Who is Eligible
  • FAQs and Training
  • Supportive Resources
FLUENZ® nasal spray suspension (influenza vaccine, live attenuated, nasal)

Flu protection
without the injection

Fluenz is the nasal spray flu vaccine within the UK Childhood Flu National Immunisation Programme.

If the nasal spray is not suitable, an alternative injectable flu vaccine may be offered.

Flu vaccination can help protect children

Fluenz is indicated for active immunisation for the prevention of influenza disease in children and adolescents from 2 years to less than 18 years of age. Fluenz should be used in accordance with official recommendations.1

Discover Fluenz

The importance of vaccination

Find out more about how the childhood flu National Immunisation Programme can help protect children and how flu can impact the wider community. In data released each flu season, you can see how your community is affected and how successful uptake of the vaccine programme is.

Read more

Who is eligible for vaccination?

Each year, the UK government and the devolved nations determine who is eligible to receive a free flu vaccine as part of the childhood flu National Immunisation Programme. This initiative supports the NHS and social care services during the winter season.

Discover eligible cohorts

 

Resources for you and those you care for

Explore a suite of print and digital resources for the teams delivering the childhood flu National Immunisation Programme. These materials are designed to support you in administering the Fluenz nasal spray vaccine in schools and practices and help you provide more information for parents and carers. Access supportive resources below.

For You For those you care for

Website for parents and carers

Discover this parent and carer website, which provides public facing information on the childhood flu National Immunisation Programme.

Visit the website

Administration video

Watch a 5-minute video demonstrating how to administer the Fluenz nasal spray vaccine to children.

Watch the video

Fluenz administration resources

Access and download resources covering the storage and administration of the Fluenz nasal spray vaccine.

Access now

Stickers

Order stickers which children can receive after they are vaccinated.

 

Order materials

Parent and carer leaflet

Order informative leaflets in a range of languages for parents and carers on why the flu vaccine matters.

Order now

Get in touch to learn more

The AZExchange team can support you in delivering the childhood flu National Immunisation Programme. Fill out our contact form to request a call back. 

Request a call back
  1. first
  2. second

Get in touch

Request a call back from a member of the AZExchange team to access further immunisation support.

Contact form

Sign up for more information

Stay up-to-date with the latest promotional and non-promotional service and product information.

Consent to communication

  1. Fluenz Trivalent nasal spray suspension Influenza vaccine (live, nasal). Summary of Product Characteristics. Accessed July 2025. Available at: https://www.medicines.org.uk/emc/product/15790/smpc

GB-68522 | June 2025

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com/ or by calling ‌‌‌0‌‌‌8‌‌‌‌‌0‌‌‌‌0‌‌‌ ‌‌7‌‌‌‌‌‌8‌‌‌3‌‌‌ ‌‌0‌‌‌‌‌0‌‌‌‌3‌‌‌‌3‌‌‌.

Connessiallasalute.it

This website was created for UK HCPs and has been designed to provide information to educate, empower and enable them in the great work they are doing for patients across a range of therapy areas. This website is intended for doctors, nurses, and pharmacists in the UK. Other UK residents please visit astrazeneca.co.uk.

Terms of use

Privacy Policy

Cookie Policy

Contact Us

LinkedIn

Twitter

©2024 AstraZeneca. GB-75991 | April 2026